retatrutide phase 2 diabetes trial Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized 2a Retatrutide, a TRIPLE agonist (GLP1,

[1] [4] This reduces the risk of hypoglycaemia compared to some other diabetes medications, though this risk increases when combined with insulin or sulfonylureas

Obesity is more than a number on the scale: your fat cells act like mini chemical factories, pumping out molecules such as IL-6, TNF-alpha, and IL-17 that keep your immune system stuck in attack mode

According to the Centers for Disease Control and Prevention (CDC), nearly 23% of those who are overweight and 31% of those who are obese have been diagnosed with arthritis by a doctor

Local Expertise We understand the needs of the Southlake community and serve nearby areas, including Mansfield and Grand Prairie

Eli Lilly introduced their new weight loss drug Zepbound (tirzepatide) back in November 2023 to rave reviews and clinical trials that showed it to be a possible game changer for those struggling with obesity